Choroideremia: from genetic and clinical phenotyping to gene therapy and future treatments
Choroideremia is an X-linked inherited chorioretinal dystrophy leading to blindness by late adulthood. Choroideremia is caused by mutations in the CHM gene which encodes Rab escort protein 1 (REP1), an ubiquitously expressed protein involved in intracellular trafficking and prenylation activity. The...
Main Authors: | Andreas Mitsios, Adam M. Dubis, Mariya Moosajee |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2018-12-01
|
Series: | Therapeutic Advances in Ophthalmology |
Online Access: | https://doi.org/10.1177/2515841418817490 |
Similar Items
-
Update on Gene Therapy Clinical Trials for Choroideremia and Potential Experimental Therapies
by: Alessandro Abbouda, et al.
Published: (2021-01-01) -
Longitudinal Study to Assess the Quantitative Use of Fundus Autofluorescence for Monitoring Disease Progression in Choroideremia
by: Adam M Dubis, et al.
Published: (2021-01-01) -
Genetic analysis and clinical phenotype of two Indian families with X-linked choroideremia
by: Rajani Battu, et al.
Published: (2016-01-01) -
Genetic testing for choroideremia
by: Abeshi Andi, et al.
Published: (2017-10-01) -
Molecular Therapies for Choroideremia
by: Jasmina Cehajic Kapetanovic, et al.
Published: (2019-09-01)